Although different in biochemical and molecular characteristics, dysregulation of both SAT and VAT contribute to the metabolic syndrome, correlating with disruption of free fatty acid metabolism, ectopic fat deposition in organs and skeletal muscle, increased inflammation, and insulin resistance [42]. This evidence concerns the gene INS and metabolic syndrome.